Baldwin Group is going private in a $7.7 billion all-cash deal led by Sequence Holdings and DFO Management, offering shareholders $32.50 per share, an 88% premium over the June 2026 price. The transaction will delist Baldwin from Nasdaq and is expected to close in early 2027, pending approvals. William Blair downgraded the stock to Market Perform due to limited upside, while law firms launched investigations into whether the deal fairly values shareholders and if the board acted properly.
BTIG increased its price target for Cullinan Therapeutics to $40, reflecting a potential 93% upside from the current stock price of around $20.73. This upgrade follows successful Phase 3 trial results for zipalertinib, a treatment for non-small cell ...
Kroger reported mixed Q2 earnings with adjusted EPS of $1.09 beating estimates, but revenues slightly below expectations at $34.62 billion. Despite slower sales growth, Kroger maintained its full-year adjusted EPS guidance of $5.10 to $5.30, supporte...
Investor Michael Burry criticized leaders of AI companies like OpenAI and Anthropic for urging a slowdown in AI development, calling their calls "self-serving" and a cover for uncontrollable slowing growth. He argued that these companies are using fe...
Two employees of the cryptocurrency exchange Binance were temporarily detained at airports in the United Arab Emirates during police investigations related to third-party fund flows. A company spokesperson confirmed that the employees have been clear...
Grayscale introduced a Bitcoin-free model portfolio heavily weighted with XRP at 26.11%, alongside Ethereum and Solana, aimed at simplifying crypto investing for financial advisors. The portfolio, launched in July 2026, has generated a 30.69% return ...
